pharmaceutical sector

Serbia’s Biotech Sector Poised for Growth Amidst Regional Opportunities

Serbia's biotechnology and pharmaceutical sectors are beginning to shift from their traditionally limited scope towards more significant industrial potential. Despite the country's strong academic foundations in medicine, chemistry, molecular biology, and software development, much of its talent has historically been directed towards foreign companies or low-value service roles rather than fostering a robust domestic biotech industry. This trend is expected to become more pronounced by 2026, as changes in Europe's healthcare and pharmaceutical landscape influence investment patterns. The European market…